Related Articles
Establishment of a bioluminescent MDA-MB-231 cell line for human triple-negative breast cancer research
MicroRNA‑27a promotes tumorigenesis via targeting AKT in triple negative breast cancer
GBP2 enhances paclitaxel sensitivity in triple‑negative breast cancer by promoting autophagy in combination with ATG2 and inhibiting the PI3K/AKT/mTOR pathway
Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers
Knockdown of SASS6 reduces growth of MDA‑MB‑231 triple‑negative breast cancer cells through arrest of the cell cycle at the G2/M phase